CNS & Neurological Disorders - Drug Targets
Title:Meet Our Section Editor
Volume: 19 Issue: 5
Author(s): Yumin Luo
Affiliation:
Export Options
About this article
Cite this article as:
Luo Yumin , Meet Our Section Editor, CNS & Neurological Disorders - Drug Targets 2020; 19 (5) . https://dx.doi.org/10.2174/187152731905201012091023
DOI https://dx.doi.org/10.2174/187152731905201012091023 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
13
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
Current Medicinal Chemistry Primary Prevention of Ischaemic Stroke in Atrial Fibrillation: New Oral Anticoagulant Drugs for all?
Current Vascular Pharmacology Nicotinic Acid and its Derivatives: Synthetic Routes, Crystal Forms and Polymorphs
Current Drug Discovery Technologies The Challenge of microRNA as a Biomarker of Epilepsy
Current Neuropharmacology Acknowledgements to Reviewers
Current Hypertension Reviews Resveratrol and Cardiac Fibrosis Prevention and Treatment
Current Pharmaceutical Biotechnology Deubiquitinating Enzymes as Therapeutic Targets in Cancer
Current Pharmaceutical Design Meet Our Regional Editor
Current Vascular Pharmacology Estimation of Familial Combined Hyperlipoproteinemia Prevalence in a Large Rural Population: The Brisighella Heart Study
Vascular Disease Prevention (Discontinued) A Novel Neuroimaging Model to Predict Early Neurological Deterioration After Acute Ischemic Stroke
Current Neurovascular Research Mechanisms And Prevention Of TAVI-Related Cerebrovascular Events
Current Pharmaceutical Design Enzyme Inhibition by Peroxynitrite-Mediated Tyrosine Nitration and Thiol Oxidation
Current Enzyme Inhibition Preface
Cardiovascular & Hematological Agents in Medicinal Chemistry Editorial: Growing Researches Responding to the Booming of Cardiovascular and Metabolic Diseases in China and Canada
Cardiovascular & Hematological Disorders-Drug Targets Inhibition of Ataxia Telangiectasia-p53-E2F-1 Pathway in Neurons as a Target for the Prevention of Neuronal Apoptosis
Current Drug Metabolism Bioprecursor Prodrugs: Molecular Modification of the Active Principle
Mini-Reviews in Medicinal Chemistry Recent Advances in Nanotechnology-Based Drug Delivery Approaches for Alzheimer disease
Current Drug Targets Preface:
Current Vascular Pharmacology Antithrombotic Therapy for Peripheral Revascularisation
Current Vascular Pharmacology Recent Pharmacoproteomics Studies of Warfarin in the Asia-Pacific: A New Strategy for Personalized Medicine?
Current Pharmacogenomics and Personalized Medicine